BR9610601A - 2-[2-[(2-hidroxietil)amino]etil]-5-[[2-metilamino)-etil]ami no]-indazol[4,3-gh]isoquinolin-6(2h)-ona como agente antitumoral. - Google Patents

2-[2-[(2-hidroxietil)amino]etil]-5-[[2-metilamino)-etil]ami no]-indazol[4,3-gh]isoquinolin-6(2h)-ona como agente antitumoral.

Info

Publication number
BR9610601A
BR9610601A BR9610601-8A BR9610601A BR9610601A BR 9610601 A BR9610601 A BR 9610601A BR 9610601 A BR9610601 A BR 9610601A BR 9610601 A BR9610601 A BR 9610601A
Authority
BR
Brazil
Prior art keywords
ethyl
amino
isoquinolin
indazole
methylamino
Prior art date
Application number
BR9610601-8A
Other languages
English (en)
Inventor
Ernesto Menta
Ambrogio Oliva
Silvano Spinelli
Paul Krapcho
Original Assignee
Boehringer Mannheim Italia
Univ Vermont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Italia, Univ Vermont filed Critical Boehringer Mannheim Italia
Publication of BR9610601A publication Critical patent/BR9610601A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: <B>"2[2-[(2-HIDROXIETIL)AMINO]ETIL]-5-[[2-METIL-AMINO)-ETI L]AMINO[INDAZOL[4,3-gh]ISOQUINOLIN -6-(2H)-ONA COMO AGENTE ANTITUMORAL"<D>. A presente invenção refere-se a 2-[2-[(2-hidroxietil)amino]etil]-5-[[2-metilamino)-etil]amino]indazol[4, 3-gh]isoquinolin-6(2h)-ona e a seus sais de adição de ácido farmaceuticamente aceitáveis, de fórmula (I). Esse composto mostrou alta atividade antitumoral.
BR9610601-8A 1995-09-13 1996-09-09 2-[2-[(2-hidroxietil)amino]etil]-5-[[2-metilamino)-etil]ami no]-indazol[4,3-gh]isoquinolin-6(2h)-ona como agente antitumoral. BR9610601A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI001904A IT1277576B1 (it) 1995-09-13 1995-09-13 2-2-(2-idrossietil) ammino etil -5- 2-metilammino etil ammino indazolo 4,3-gh isochinolin-6 (2h)-one come agente antitumorale
PCT/EP1996/003935 WO1997010245A1 (en) 1995-09-13 1996-09-09 2-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-5-[[2-METHYLAMINO)ETHYL]AMINO]INDAZOLO[4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT

Publications (1)

Publication Number Publication Date
BR9610601A true BR9610601A (pt) 1999-12-21

Family

ID=11372237

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610601-8A BR9610601A (pt) 1995-09-13 1996-09-09 2-[2-[(2-hidroxietil)amino]etil]-5-[[2-metilamino)-etil]ami no]-indazol[4,3-gh]isoquinolin-6(2h)-ona como agente antitumoral.

Country Status (15)

Country Link
US (1) US6034092A (pt)
EP (1) EP0876369A1 (pt)
JP (1) JPH11512409A (pt)
KR (1) KR19990044614A (pt)
CN (1) CN1196055A (pt)
AR (1) AR003997A1 (pt)
AU (1) AU6988296A (pt)
BR (1) BR9610601A (pt)
CZ (1) CZ286654B6 (pt)
HU (1) HUP9901348A3 (pt)
IL (1) IL123619A0 (pt)
IT (1) IT1277576B1 (pt)
NO (1) NO981093D0 (pt)
WO (1) WO1997010245A1 (pt)
ZA (1) ZA967706B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747039B2 (en) * 2002-03-12 2004-06-08 Albany Molecular Research, Inc. Aza-benzothiopyranoindazoles with antitumor activity
EP1871367A2 (en) * 2005-01-28 2008-01-02 Xanthus Pharmaceuticals, Inc. Compounds for treating inflammatory and demyelinating diseases
CN103787970A (zh) * 2014-01-14 2014-05-14 北京万全德众医药生物技术有限公司 一锅煮法制备6，9-二氟苯并异喹啉-5，10-二酮的工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69211A (en) * 1982-07-23 1987-01-30 Warner Lambert Co Substituted anthra(1,9-cd)pyrazol-6(2h)-ones,their preparation and pharmaceutical compositions containing them
US5519029A (en) * 1992-09-08 1996-05-21 Boehringer Mannheim Italia, S.P.A. 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones
ES2155452T3 (es) * 1992-09-08 2001-05-16 Univ Vermont Isoquinoindazol-6-(2h)-onas sustituidas con 2-aminoalquil-5-aminoalquilamino con actividad antitumoral.
US5596097A (en) * 1994-03-08 1997-01-21 The University Of Vermont Hetero-annulated indazoles

Also Published As

Publication number Publication date
IL123619A0 (en) 1998-10-30
WO1997010245A1 (en) 1997-03-20
HUP9901348A3 (en) 2000-03-28
KR19990044614A (ko) 1999-06-25
ZA967706B (en) 1997-03-25
AU6988296A (en) 1997-04-01
US6034092A (en) 2000-03-07
ITMI951904A1 (it) 1997-03-13
HUP9901348A2 (hu) 1999-08-30
IT1277576B1 (it) 1997-11-11
AR003997A1 (es) 1998-09-30
ITMI951904A0 (it) 1995-09-13
CN1196055A (zh) 1998-10-14
JPH11512409A (ja) 1999-10-26
CZ75098A3 (cs) 1998-07-15
CZ286654B6 (cs) 2000-05-17
NO981093L (no) 1998-03-12
EP0876369A1 (en) 1998-11-11
NO981093D0 (no) 1998-03-12

Similar Documents

Publication Publication Date Title
MY114389A (en) Aqueous risperidone formulations
GR3032311T3 (en) Stilbene derivatives and pharmaceutical compositions containing them
CA2086654A1 (en) Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them
CA2044746A1 (en) Polypeptide compound and a process for preparation thereof
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
CA2160447A1 (en) Amino(thio)ether derivatives
MXPA02005536A (es) Acidos aminopropilfosfinicos novedosos.
LU90956I2 (fr) Metvix principe actif méthylaminolevulinique sous forme d&#39;un selde préférence l&#39;hyhrochlorure méthylaminolevulinique
EP1068219A4 (en) ACYLATED BETULIN AND DIHYDROBETULIN DERIVATIVES, THEIR PREPARATION AND USE
AU5993896A (en) Semicarbazones having cns activity and pharmaceutical preparations containing same
EP1140900A4 (en) PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS
CA2245174A1 (en) Treatment of contact lenses with an aqueous solution including sulfobetaine compounds
CA2192975A1 (en) Benzimidazolone Derivatives
MY131641A (en) Indoline derivatives, process of preparation and use
CA2234319A1 (en) Fluoro-substituted adamantane derivatives
TW324662B (en) Benzamide-containing pharmaceutical composition
AU2351095A (en) Benzimidazole derivatives having dopaminergic activity
SI0808326T1 (en) Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
BR9610601A (pt) 2-[2-[(2-hidroxietil)amino]etil]-5-[[2-metilamino)-etil]ami no]-indazol[4,3-gh]isoquinolin-6(2h)-ona como agente antitumoral.
BG102342A (en) Optical active derivative of phenylpyrimidine as an anlgesics
SI0801655T1 (en) Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
BR9812982A (pt) Agente anti-reumático
EP0842663A4 (en) OPHTHALMIC PREPARATIONS
UA41880C2 (uk) Серотонінергічні похідні ерголіну і фармацевтична композиція
CA2202904A1 (en) Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
FA14 Dismissal: dismissal - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]